Inhibition of the renin-angiotensin system for prevention of atrial fibrillation

Pacing and Clinical Electrophysiology : PACE
Theodoros Zografos, Demosthenes G Katritsis

Abstract

Atrial fibrillation (AF) is a source of considerable morbidity and mortality. There has been compelling evidence supporting the role of renin-angiotensin system (RAS) in the genesis and perpetuation of AF through atrial remodeling, and experimental studies have validated the utilization of RAS inhibition for AF prevention. This article reviews clinical trials on the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) for the prevention of AF. Results have been variable, depending on the clinical background of treated patients. ACEIs and ARBs appear beneficial for primary prevention of AF in patients with heart failure, whereas they are not equally effective in hypertensive patients with normal left ventricular function. Furthermore, the use of ACEIs or ARBs for secondary prevention of AF has been found beneficial only after electrical cardioversion. Additional data are needed to establish the potential clinical role of renin-angiotensin inhibition for prevention of AF.

References

Nov 1, 1992·Pacing and Clinical Electrophysiology : PACE·H CalkinsF Morady
Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Oct 1, 1989·Cardiovascular Research·F SoltiA Juhász-Nagy
May 22, 1993·Lancet·F D Murgatroyd, A J Camm
Oct 1, 1995·Journal of Molecular and Cellular Cardiology·A A LeeF J Villarreal
Feb 1, 1997·Stroke; a Journal of Cerebral Circulation·A OttA Hofman
Feb 24, 1998·Archives of Internal Medicine·P A WolfR B D'Agostino
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Jun 24, 2000·Circulation Research·H J Jongsma, R Wilders
Sep 26, 2000·Molecular Genetics and Metabolism·P J LijnenR H Fagard
May 9, 2001·Nature·F BodeM R Franz
Apr 12, 2003·Pacing and Clinical Electrophysiology : PACE·Francesca GensiniAntonio Michelucci
Jun 25, 2003·Journal of the American College of Cardiology·Koichiro KumagaiKeijiro Saku
Dec 1, 1995·Journal of Cardiac Failure·M P Van Den BergK I Lie
Mar 17, 2004·Circulation·Chia-Ti TsaiYung-Zu Tseng
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Joseph P MathewUNKNOWN Multicenter Study of Perioperative Ischemia Research Group
Jul 6, 2004·Journal of the American College of Cardiology·Philippe L L'AllierJean-Claude Tardif
Nov 5, 2004·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Antonio H MadridConcepción Moro

❮ Previous
Next ❯

Citations

Feb 24, 2015·International Journal of Cardiology·Hong LianLianfeng Zhang
Nov 26, 2015·Cardiovascular Research·Tanja K RudolphVolker Rudolph
Apr 6, 2013·International Journal of Clinical Practice·T-J LiX-D Li
Jan 7, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Andrew M Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.